| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10158391 | Clinical Therapeutics | 2018 | 11 Pages |
Abstract
Overall, this study supports the further evaluation of sofosbuvir 400mg in the Chinese population. The pharmacokinetic properties of sofosbuvir, GS-556500, and GS-311007 were found to be broadly similar in healthy Chinese subjects compared with non-Chinese subjects in previous sofosbuvir studies. ChinaDrugTrials.org.cn identifier: CTR20150249.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Xiaojiao MS, Hong MS, Junqi MD, Guiling MS, Gong PhD, Benedetta MD, Diana M. MD, Xiaoxue MS, Hong MD, Yanhua MD,